Genetic variations frequencies in Wilms' tumor: a meta-analysis and systematic review

Over the last few decades, numerous biomarkers, have been confirmed and shown variations in the prevalence. Most of these studies were based on small sample sizes. We carried out a meta-analysis of the research published up to 15 September 2015 to obtain more precise and comprehensive outcome for genetic tests.

In the present study, 70 studies out of 5175 papers were eligible for meta-analysis. Meta-analysis was done with Stata 12. 0. Pooled prevalence for gene mutations (WT1, WTX, CTNNB1, TP53, MYCN, DROSHA and DGCR8) was 0. 147 (0. 109, 0. 185), 0. 149 (0. 110, 0. 186), 0. 140 (0. 100, 0. 190), 0. 474 (0. 342, 0. 606), 0. 099 (0. 063, 0. 136), 0. 096 (0. 050, 0. 141) and 0. 037 (0. 025, 0. 049), respectively. Pooled prevalence of LOH at 1p, 11p, 11q, 16q, and 22q was 0. 109 (0. 084, 0. 133), 0. 334 (0. 295, 0. 373), 0. 199 (0. 146, 0. 252), 0. 151 (0. 129, 0. 172) and 0. 148 (0. 108, 0. 189), respectively. Pooled prevalence of 1q and chromosome 12 gain was 0. 218 (0. 161, 0. 275) and 0. 273 (0. 195, 0. 350). The limited prevalence of currently known genetic alterations in Wilms' tumors indicates that significant drivers of initiation and progression remain to be discovered. Subgroup analyses indicate that the ethnicity maybe one of the sources of heterogeneity. However, in meta regression analyses, No study-level characteristics of indicators were found significant. In addition, Sensitivity analysis and the publication bias of some results hint us interpret those results with caution. This article is protected by copyright. All rights reserved.

Cancer science. 2016 Feb 19 [Epub ahead of print]

Changkai Deng, Rong Dai, Xuliang Li, Feng Liu

Department of Urology Surgery, Children's Hospital, Ministry of Education Key Laboratory of Child Development and Disorder, Key Laboratory of Pediatrics in Chongqing (CSTC2009CA5002), Chongqing International Science and Technology Cooperation Center for Child Development and Disorders, Chongqing Medical University, No. 136, Zhongshan 2 RD, Yuzhong District, Chongqing, 400014, China. , Chengdu Center for Disease Control and Prevention, No. 4, Longxiang RD, Wuhou District, Chengdu, 610041, China. , Department of Urology Surgery, Children's Hospital, Ministry of Education Key Laboratory of Child Development and Disorder, Key Laboratory of Pediatrics in Chongqing (CSTC2009CA5002), Chongqing International Science and Technology Cooperation Center for Child Development and Disorders, Chongqing Medical University, No. 136, Zhongshan 2 RD, Yuzhong District, Chongqing, 400014, China. , Department of Urology Surgery, Children's Hospital, Ministry of Education Key Laboratory of Child Development and Disorder, Key Laboratory of Pediatrics in Chongqing (CSTC2009CA5002), Chongqing International Science and Technology Cooperation Center for Child Development and Disorders, Chongqing Medical University, No. 136, Zhongshan 2 RD, Yuzhong District, Chongqing, 400014, China.

PubMed

E-Newsletters

Newsletter subscription

Free Daily and Weekly newsletters offered by content of interest

The fields of GU Oncology and Urology are rapidly advancing. Sign up today for articles, videos, conference highlights and abstracts from peer-review publications by disease and condition delivered to your inbox and read on the go.

Subscribe